Viatris Inc. operates as a pharmaceutical company. The Company produces medicines for patients across broad range of major therapeutic areas spanning both noncommunicable and infectious diseases. Viatris serves clients worldwide.

Current Report (Form 8-K | Period ending 2024-12-06)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Viatris (VTRS US)

Current Report (Form 8-K | Period ending 2024-12-06)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-07)

Annual Report to Security Holders (Form ARS | Period ending 2023-12-31)

Current Report (Form 8-K | Period ending 2024-09-27)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)